Quarterly ResultMay 7, 2026, 06:03 AM
LifeStance Q1 Revenue $403.5M, Net Income $14.2M; Raises FY26 Outlook
AI Summary
LifeStance Health Group reported strong financial results for the first quarter ended March 31, 2026, with revenue increasing 21% to $403.5 million and net income rising significantly to $14.2 million. Adjusted EBITDA also saw substantial growth, up 48% to $51.1 million. The company expanded its clinician base by 11% and increased visit volumes by 18%. Following this performance, LifeStance raised its full-year 2026 guidance for revenue, Center Margin, and Adjusted EBITDA, reflecting confidence in its differentiated model and growing demand for mental healthcare.
Key Highlights
- Q1 2026 revenue was $403.5 million, an increase of 21% year-over-year.
- Q1 2026 net income was $14.2 million, compared to $0.7 million in Q1 2025.
- Q1 2026 Adjusted EBITDA increased 48% to $51.1 million.
- Clinician base grew 11% to 8,349, with a sequential net increase of 309.
- First quarter visit volumes increased 18% to 2.5 million.
- Full-year 2026 revenue expectations raised to $1.640 billion to $1.680 billion.
- Full-year 2026 Adjusted EBITDA expectations raised to $200 million to $220 million.
- Generated $22.3 million in Free Cash Flow in the first quarter.